Indication
Lipid
2 clinical trials
4 products
1 drug
Clinical trial
A 24-week, Multi-center, Randomized, Open-Label Clinical Trial to Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes (XTREME Study)Status: Completed, Estimated PCD: 2024-04-02
Product
XuezhikangProduct
AtorvastatinClinical trial
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusStatus: Recruiting, Estimated PCD: 2025-02-23
Product
LiraglutideProduct
SemaglutideDrug
Metformin